Surge in Demand: Cell & Gene Therapy Drug Delivery Devices Market Growth at 14% CAGR by 2028

Overview of Cell Gene Therapy Drug Delivery Devices Market Size Future Outlook

According to the latest report by MarkNtel Advisors, the Global Cell Gene Therapy Drug Delivery Devices Market size is estimated to grow at a CAGR of around 14% from 2023-2028. This report is designed to enhance user understanding and support informed decision-making by thoroughly analyzing key market shifts, identifying gaps, exploring emerging opportunities, and assessing industry trends and competitive challenges. By combining both qualitative and quantitative data, it offers a comprehensive overview, highlighting growth prospects and providing valuable insights into competitors, helping both established companies and new entrants navigate the current market landscape.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

What are the key drivers influencing the growth of the Cell Gene Therapy Drug Delivery Devices market?

This section provides a detailed analysis of the market drivers and factors is explored thoroughly below.

The factors that are projected to drive the market in the coming years include the following:

Substantial investments in RD, particularly across the US, for the development of new improved cell gene therapies
Mounting prevalence of genetic disorders chronic diseases
An increasing number of FDA approvals for cell gene therapies their clinical trial.

How is the Cell Gene Therapy Drug Delivery Devices market segmented and what are the key factors within each segment?

The Cell Gene Therapy Drug Delivery Devices market has been further segmented into distinct categories. Analyzing growth within these segments allows you to identify niche opportunities, develop targeted strategies, and understand the variations in your core application areas and target markets.

By Product Type

Sub-retinal Injection Cannula
Extension Tube
Intravenous Catheter
Sterile Insulin Syringe

Size 1.0 ML, 31-Gauge Needle
Size 0.5 ML, 22-Gauge Needle

Pre-Filled Syringe

Size 1.0 ML, 22-26 Gauge Needle
Size 4.0 ML, 22-26 Gauge Needle

Infusion Bags

Infusion Bags (Size 10 ML to 50 ML)
Infusion Bags (Size 68 ML)
Infusion Bags (Size 60 ML)
Infusion Bags (Size Up to 65 ML)

By Technology

Microchip Technology
Nano-Technology
Lipid Nanoparticles

By Commercialized Drugs

Luxturna
Kymriah
Yescarta
Zolgensma
Provenge
Strimvelis

By End-User

Pharmaceuticals Biotechnology Company
Academic Research Institute
Hospitals Clinics

By Region

North America
South America
Europe
Middle East Africa
Asia-Pacific..

Browse Full Report Along with TOC and Figures -

Who are the Key Market Players in the Cell Gene Therapy Drug Delivery Devices industry?

The competitive landscape of the Cell Gene Therapy Drug Delivery Devices market provides a detailed look at the key players in the industry. This includes an overview of each company, their financial performance, revenue generation, and market potential. It also covers their investments in RD, new market initiatives, production facilities, and strengths and weaknesses. Additionally, the analysis looks at recent product launches, approvals, the range of products offered, their dominance in different applications, and the product life cycle. All of this information is specifically focused on how each company is positioning itself within the market.

Several key players are actively operating in the market, including

Amgen Inc.
Bausch Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio Inc.
Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
Dendreon Pharmaceuticals LLC
Helixmith Co. Ltd (ViroMed Co., Ltd)
Human Stem Cells Institute
Kite Pharma Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer Inc.
Renova Therapeutics
Spark Therapeutics Inc.
uniQure N.V.
Vericel Corporation.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

Other Report:

Why Choose MarkNtel Advisors:

Focused Industry Expertise
Diverse Report Offerings
Personalized Research Solutions
Robust Research Methodology
In-depth Report Coverage
Tracking Technological Advancements
Comprehensive Value-Chain Analysis
Discovering Market Opportunities
Analyzing Growth Trajectories
Assured Quality Insights
Dedicated After-Sales Support
Trusted by Fortune 500 Companies

About Us –

We are a leading market research company, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.

Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Call + +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com